The early phase of leptospiral infection is characterized by the presence of live organisms in the blood. Pathogenic Leptospira interrogans is resistant to the alternative pathway of complement mediated-killing, while nonpathogenic members of the genus are not. Consistent with that observation, only pathogenic leptospires bound factor H, a host fluid-phase regulator of the alternative complement pathway. Ligand affinity blot analyses revealed that pathogenic L. interrogans produces at least two factor H-binding proteins. Through screening of a lambda phage expression library, we identified one of these as the novel membrane protein LfhA. Ligand affinity assays and surface plasmon resonance analyses of recombinant LfhA revealed specific binding of both factor H and factor H-related protein 1. Serological examination of infected humans and horses demonstrated that LfhA is expressed by L. interrogans during mammalian infection. LfhA may therefore contribute to the resistance of pathogenic leptospires to complement-mediated killing during leptospiremic phases of the disease.
gen surfaces and unleashes a cascade of reactions resulting in formation of lytic membrane attack complexes, opsonization of pathogens, and phagocyte recruitment. Complement activation can also enhance host adaptive immune responses (9) . Damage to host cells by complement activation is prevented by a number of complement-regulatory proteins, including factor H (23) . Factor H, a 150-kDa plasma protein, is present in serum at a concentration of approximately 500 g/ml and is composed of 20 short consensus repeats (SCRs) (51) . Factor H binds to C3b by displacing Bb from C3 convertases and acts as a cofactor for factor I, which cleaves C3b to its inactive form, iC3b. Humans, but not all other mammals, produce a smaller protein, factor H-like protein 1 (FHL-1), by alternative splicing of the factor H gene. FHL-1 consists of the first seven SCRs of factor H plus four additional amino acids at the carboxy terminus, and it exhibits cofactor activity (62) . Mammals also produce several factor H-related proteins (FHRs), from distinct genes, which share sequence similarity with the carboxy terminus of factor H (45, 62) . The FHRs are not yet well characterized but appear to also possess complement-regulatory functions (20, 39, 49, 62) . Terminal sialic acid moieties on vertebrate cell glycoproteins serve as receptors to bind factor H and related proteins to cell surfaces, where they serve to protect those cells against the deleterious effects of C3 activation (23, 61) .
During the leptospiremic phase, the bacteria are exposed to components of the alternative pathway of complement but readily avoid complement-mediated destruction (3, 5, 10, (24) (25) (26) . The ability of pathogenic leptospires to resist the alternative pathway of complement was noticed several decades ago and proposed as a virulence determinant (10, 24) , although the exact mechanism underlying this resistance was not defined. Many other pathogens have evolved mechanisms to bind host factor H to their surfaces, thereby protecting themselves from the destructive effects of complement activation (35, 37, 62) . Several bacterial pathogens of medical and veterinary importance, including Lancefield group A/B streptococci (15, 44) , Neisseria meningitidis and Neisseria gonorrhoeae (48) , Borrelia burgdorferi (1, 2, 8, 21, 30-34, 38, 56) and Borrelia hermsii (22) , produce one or more outer surface proteins that specifically bind factor H. Given the widespread distribution of factor H-binding proteins among bacterial pathogens, we speculated that such proteins might also be responsible for resistance of L. interrogans to complement-mediated killing. To address this hypothesis, pathogenic leptospires were examined for the ability to bind factor H, whereupon we discovered that these bacteria produce at least two different factor H-binding proteins. During the preparation of this paper, another research group published data also indicating that pathogenic leptospires bind factor H to their surfaces (40) , although the molecular nature of the interactions was not explored in that study. In this report we present data on the identification and biophysical characterization of LfhA, a factor H-binding protein of infectious Leptospira species.
trocellulose membranes and blocked with 5% nonfat dry milk in Tris-buffered saline-Tween 20 (TBS-T) (20 mM Tris, 150 mM NaCl, 0.05% Tween 20 [pH 7.5]). The membranes were then incubated with either purified human factor H (0.5 g /ml; Calbiochem) or normal equine serum for 1 h at RT. Following washing with TBS-T, membranes were incubated for 1 h at RT with monoclonal anti-factor H antibody A229 (27) (Quidel). Finally, the membranes were washed with TBS-T and incubated for 1 h at RT with horseradish peroxide-conjugated sheep anti-mouse antibodies (Amersham, Little Chalfont, United Kingdom). Bound antibodies were identified either by enhanced chemiluminescence (Pierce, Rockford, IL) or by using 12 mg 4-chloro-1-naphthol (Sigma) dissolved in 5 ml methanol, 25 ml TBS, and 30 l of 30% hydrogen peroxide. Recombinant forms of ErpA and ErpC, two factor H-binding proteins of the spirochete Borrelia burgdorferi (1, 30, 32, 41, 56) , were used as positive control proteins for all analyses. Carbonic anhydrase, soybean trypsin inhibitor, and lysozyme, which do not specifically bind factor H, were used as negative controls.
Library screening and sequence determination of cloned inserts. A lambda ZAP II library containing 3-to 5-kb fragments of L. interrogans serovar Pomona type kennewicki DNA (29) was screened to identify phage expressing gene products that bound with purified human factor H. Following propagation in Escherichia coli XL-1 Blue MRFЈ (Stratagene, La Jolla, CA), phage plaques were transferred in duplicate to IPTG (isopropyl-␤-D-thiogalactopyranoside)-saturated nitrocellulose disks and immunoblotted with either purified human factor H or equine serum, followed by monoclonal anti-factor H antibody, as described above. Plaques that bound factor H were transferred to 500 l of SM buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 8 mM MgSO 4 , 0.01% gelatin) and allowed to elute overnight at 4°C. Plaques were rescreened until they were clonal. Plasmids were rescued from reactive phages by using ExAssist helper phage and E. coli SOLR (Stratagene), following the supplier's protocol.
Plasmids were isolated using QIAprep spin miniprep kits (QIAGEN, Valencia, CA). Insert DNAs were sequenced by a commercial DNA sequencing facility (Davis Sequencing LLC, Davis, CA). Sequences were compared with the L. interrogans serovar Lai strain 56601 and serovar Copenhageni strain Fiocruz L1-130 genomic sequences at http://www.tigr.org/. Analyses of nucleotide sequences and deduced amino acid sequences were performed using DNASIS, SignalP (6), LipoP (28), TMHMM (http://www.cbs.dtu.dk/), COILS (http://www .ch.embnet.org/index.html), and BLAST (http://www.ncbi.nlm.nih.gov/BLAST/).
Cloning and expression of recombinant LfhA. The L. interrogans serovar Pomona strain JEN4 lfhA gene, minus its signal sequence, was amplified with PCR oligonucleotide primers LfhAF (5Ј-GCG CTC GAG GAA GAA GAT AAT TCA GAA CTA C-3Ј) and LfhAR (5Ј-GCG GAT CCT TAC TGT TCT ACA CAG AGA AGA TT-3Ј). The resulting amplicon was digested with BamHI and XhoI and inserted into pET-15b (Novagen, Madison, WI). The recombinant plasmid was transformed into E. coli Rosetta(DE3)(pLysS) (Novagen), and expression of His 6 -LfhA was induced with 1 mM IPTG. Recombinant His-tagged protein was isolated using Talon metal affinity resin (BD Biosciences Clontech, Palo Alto, CA) in buffer containing 8 M urea, following the manufacturer's recommendations. The purity of recombinant protein was confirmed by SDS-PAGE and staining with Coomassie brilliant blue.
LfhA-directed polyclonal antisera. Polyclonal LfhA antiserum was raised in a New Zealand White rabbit by a subcutaneous administration of 200 g of recombinant LfhA adsorbed to aluminum hydroxide (Alhydrogel; Accurate Chemical & Scientific Corp., Westbury, NY) and N-acetylmuramyl-L-alanyl-Disoglutamine (Sigma), followed by two subcutaneous booster injections and one intravenous booster injection. Where indicated, LfhA antiserum was affinity purified by overnight incubation with nitrocellulose membranes impregnated with 10 g of purified recombinant LfhA protein. The affinity-purified antibodies were eluted from the nitrocellulose by incubation with 100 mM glycine (pH 2.0) for 15 min at room temperature. Purified antibody solution was neutralized by addition of 0.1 volume of 1 M Tris base (pH 8.0) and subsequently dialyzed against PBS.
Surface plasmon resonance. Protein-protein interactions were analyzed by a surface plasmon resonance technique using a Biacore 3000 instrument (Biacore AB, Uppsala, Sweden) as described earlier (21) . Briefly, recombinant LfhA (40 g/ml, dialyzed against 10 mM acetate buffer, pH 5.0) was coupled via amine coupling onto the flow cell of a sensor chip (CM5; Biacore AB) until a level of Ͼ2,000 resonance units was reached. A control flow cell was prepared by injecting buffer without protein. Purified human factor H (Calbiochem, La Jolla, CA), recombinant human FHR-1 expressed in insect cells (J. Hellwage, unpublished results), and recombinant human FHL-1 (58) were individually dialyzed against the running buffer (phosphate-buffered saline, pH 7.4, 50 M NiCl 2 ). Each ligand was injected separately into the flow cell coupled with LfhA or into the control flow cell, using a flow rate of 10 l/min at 25°C. Studies were also performed using recombinant forms of B. burgdorferi proteins, including the 2660 VERMA ET AL. INFECT. IMMUN.
factor H-binding proteins BbCRASP-3 (ErpP), OspE, and BbCRASP-1 and specific deletion mutants of BbCRASP-1 and BbCRASP-3 that do not bind factor H (unpublished results and references 21 and 31). Triton X-114 extraction. L. interrogans serovar Lai was washed in PBS and then extracted with 1% protein grade Triton X-114 (Calbiochem) in PBS overnight at 4°C. The insoluble material was removed by centrifugation at 20,000 ϫ g for 30 min and incubated two more times with Triton X-114. The supernatant was removed, and phase separation was performed by warming the supernatant to 37°C and subjecting it to centrifugation for 15 min at 15,000 ϫ g (46) . The detergent and aqueous phases were then separated, reextracted thrice, and precipitated with methanol-chloroform. The integrity of the protoplasmic cylinder was checked by immunoblot analysis of Triton X-114-extracted fragments with antiserum specific for spirochete flagella (a gift of David Blanco, University of California, Los Angeles, CA).
Southern blot analysis. Genomic DNAs of L. interrogans serovars Pomona, Canicola, Grippotyphosa, Hardjo, and Bratislava and of L. biflexa, L. weilii, L. inadai, and Leptonema illini were isolated from 5-ml cultures as previously described (4) . Leptospiral DNAs were digested overnight with HindIII at 37°C. Digested DNAs were separated on a 0.8% agarose gel, transferred to a Hybond-N nylon membrane (Amersham, Piscataway, N.J.), and fixed by UV cross-linking.
The LfhAF and LfhAR primers were used to PCR amplify lfhA from L. interrogans serovar Pomona strain JEN4. The amplicon was labeled with digoxigenin using the DIG High Prime DNA labeling and detection kit (Roche, Indianapolis, IN). The UV cross-linked nylon membrane was subjected to prehybridization at 42°C for 30 min in DIG Easy hybridization solution (Roche). After denaturation, approximately 25 ng/ml of lfhA probe was mixed with DIG Easy hybridization solution and incubated with the membrane at 42°C with gentle agitation. The next day, the membrane was washed for 15 min at room temperature with three changes of buffer containing 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and 0.1% SDS. The membrane was then washed thrice for 15 min each at 65°C in 0.5ϫ SSC with 0.1% SDS. Next, the membrane was treated with antidigoxigenin-alkaline phosphatase, followed by the chemiluminescence substrate. DNA hybridization was detected by exposing the membrane to X-Omat AR film (Eastman Kodak Company, Rochester, NY).
Immunoblot analyses. For each analysis, a 10-mg aliquot of purified recombinant LfhA protein was applied to a single 7-cm-wide well in a polyacrylamide gel, subjected to SDS-PAGE, transferred to a nitrocellulose membrane, and blocked using 4% (wt/vol) nonfat dried milk in TBS-T. Serum samples from human or equine leptospirosis cases were diluted 1:100 in TBS-T and examined simultaneously using a Mini-Protean II Multiscreen apparatus (Bio-Rad). Polyclonal rabbit LfhA-directed antiserum, diluted 1:400, served as a positive control for all immunoblot analyses. Normal human or equine sera, diluted 1:100 in TBS-T, served as negative controls. Bound antibodies were detected using protein G conjugated to horseradish peroxidase (Zymed, San Francisco, CA) and 4-chloro-1-naphthol (Sigma).
Nucleotide sequence accession number. The DNA sequence of the L. interrogans serovar Pomona type kennewicki strain JEN4 library clone containing lfhA has been submitted to GenBank with accession number DQ370178.
RESULTS

Pathogenic leptospires bind host factor H.
Pathogenic leptospires survive and multiply in the bloodstreams of animals during the initial phase of the disease, in part due to their resistance to the alternative pathway of complement (3, 5, 10, (24) (25) (26) . In contrast, saprophytic leptospires are very sensitive to the killing effect of complement, presumably because their noninfectious nature has not required those bacteria to evolve complement evasion mechanisms. Those conclusions of earlier researchers were reaffirmed by the results of the present studies. Pathogenic L. interrogans serovars Lai, Pomona, Copenhageni, Canicola, Grippotyphosa, Hardjo, and Bratislava and the nonpathogenic L. biflexa were each incubated in 50% normal equine serum. After 1 h, greater than 80% of each pathogenic serovar remained intact. More than 99% of bacteria in cultures of L. biflexa were lysed under those conditions. L. biflexa was able to survive only when the concentration of normal serum was less than 5%.
Many pathogens, including the spirochetes B. burgdorferi and B. hermsii, prevent activation of the alternative pathway of complement by binding factor H via specific outer membrane proteins. To examine whether a similar mechanism is used by L. interrogans, the ability of that bacterium to bind factor H was examined by indirect immunofluorescence analysis. L. interrogans exhibited substantial factor H binding (Fig. 1) , while L. biflexa did not bind the complement regulator. Similar results were obtained when using either purified human factor H or normal equine serum. L. interrogans and L. biflexa subjected to conditions that lacked either factor H or anti-factor H monoclonal antibody did not exhibit fluorescence (not shown), indicating the specificity of this assay.
Next, we analyzed whole-cell lysates of L. interrogans serovars Lai and Pomona for the presence of proteins that interact with factor H. Factor H ligand affinity blot analysis of cell lysates from the two serovars indicated that both strains produced at least two factor H-binding proteins, having apparent molecular masses of approximately 30 and 50 kDa (Fig. 2A) . Recombinant ErpA, a factor H binding protein of B. burgdorferi (56), served as a positive control (Fig. 2A) . No signals were detected when either factor H or factor H-directed monoclonal antibody was omitted (data not shown). 
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Identification of the factor H binding protein LfhA.
A lambda expression library of L. interrogans serovar Pomona type kennewicki strain JEN4 was screened for clones that specifically bound human factor H. Reactive phage were isolated and their inserts sequenced and compared with genomic sequences of L. interrogans serovars Lai (strain 56601) (50) and Copenhageni (strain Fiocruz L1-130) (43) . Phagemid pOM1 contained two open reading frames (ORFs) in a 3,335-bp fragment of L. interrogans chromosome I DNA. The predicted amino acid sequence of one, partial ORF suggested that it encodes a 76-kDa sodium-glucose symporter. The second ORF lacked significant homology with any previously characterized protein and is allelic to ORF LA695 of L. interrogans serovar Lai and ORF LIC12906 of L. interrogans serovar Copenhageni. Those ORFs encode proteins consisting of 240 amino acid residues and predicted molecular masses of 26 kDa. The amino termini of these predicted proteins contain 28-amino-acid signal sequences followed by putative spirochetal lipoboxes, LYS2C (11, 17, 53, 54) . These and other sequence features suggested that the putative lipoprotein of phagemid pOM1 was likely to be an outer membrane protein (17, 53) , so it was chosen for further characterization.
LfhA binds factor H and FHR-1. A recombinant His 6 tag fusion protein of the putative lipoprotein was produced and tested for the ability to bind factor H. Ligand affinity blot analyses demonstrated that the recombinant L. interrogans protein bound factor H (Fig. 2B) , and it was therefore designated LfhA (for Leptospira factor H-binding protein A) .
The interaction between LfhA and factor H was characterized further using real-time surface plasmon resonance (Biacore).
LfhA was coupled to a sensor chip, and its interaction with free-flowing factor H was measured as relative resonance units. Factor H in increasing concentrations (12.5, 25, 50 , 100, and 200 nM) was injected separately into the flow cell with LfhA or into the control flow cell. LfhA bound factor H in a dosedependent manner (Fig. 3A) . In addition, LfhA also interacted with the factor H-related protein FHR-1 (Fig. 3B) , a 37-to 43-kDa plasma protein composed of five SCRs and a carboxy terminus that shares a high degree of similarity with factor H (62). LfhA did not bind FHL-1, which consists of the aminoterminal seven SCRs of factor H (data not shown). These data suggest that LfhA interacts with factor H through carboxyterminal SCRs 18 to 20, the region it has in common with FHR-1. Control studies using known factor H-binding proteins and nonbinding proteins demonstrated the sensitivity and specificity of this technique (data not shown and references 21 and 31).
Localization of LfhA to the outer and inner membranes. As noted above, analysis of the predicted amino acid sequence of LfhA revealed features characteristic of an outer surface protein. This prediction was confirmed by solubilizing L. interrogans serovar Lai with Triton X-114 to obtain protoplasmic cylinder-, periplasmic protein-, and outer membrane protein- enriched fractions. The protoplasmic cylinder fraction consists of the cytoplasm, inner membrane, and anchored periplasmic flagella (14) . Outer membrane components are found in the detergent-soluble fraction, whereas periplasmic proteins separate into the aqueous phase (13, 42, 46, 47, 55, 57) . Fractions were subjected to SDS-PAGE and analyzed by immunoblotting (Fig. 4) . The integrity of the protoplasmic cylinder was confirmed using polyclonal antiserum that recognizes leptospiral flagella (42) . LfhA was identified in both the outer membrane and protoplasmic cylinder fractions, as has previously been reported for another L. interrogans protein, LipL41 (55) . Infectious L. interrogans contains lfhA loci. We next investigated the distribution of lfhA genes in several different pathogenic and saprophytic Leptospira spp. As described above, examination of the published genome sequences of L. interrogans serovars Lai and Copenhageni indicated that lfhA is present in those two serovars. The near identity of the nucleotide sequences of lfhA genes of L. interrogans isolates from the United States and China (50) and Brazil (43) suggests a high degree of conservation of the gene among L. interrogans strains. Southern blot analysis using a probe derived from the serovar Pomona lfhA gene confirmed the presence of the gene in each examined L. interrogans serovar (Fig. 5) . Homologs of lfhA
LfhA is expressed during natural infection. Next, we queried whether LfhA is expressed by L. interrogans during mammalian infection and would thus be poised to protect the bacterium from complement-mediated killing. To that end, recombinant LfhA was examined by immunoblotting using sera from human and equine cases of leptospirosis. Thirteen of 14 human sera and all 13 equine sera contained antibodies that bound recombinant LfhA (Fig. 6 ). Control normal human and equine sera did not contain antibodies recognizing LfhA. Thus, not only is LfhA synthesized by L. interrogans during mammalian infections, but it also appears to be highly antigenic. Moreover, recognition of recombinant LfhA derived from serovar Pomona by such a wide diversity of infected humans and horses suggests extensive antigenic conservation of LfhA among many infectious leptospires.
DISCUSSION
The broad host range of pathogenic leptospires indicates an ability to overcome the antimicrobial defense systems of a wide variety of animals. Following entry through the skin or mucosa, L. interrogans is exposed to the innate humoral and cellular defense systems, which normally disarm and remove less virulent microbial intruders. Initial leptospiral infection is followed by bacteremia that persists through the incubation period and for 1 to 2 weeks after onset of acute disease. Multiplication in susceptible hosts is rapid, with doubling times of 8 h or less for virulent strains that cause acute fulminating disease (14) . In contrast, nonpathogenic leptospires are readily killed by animal innate immune defenses. Early studies designed to explain FIG. 4 . Cellular localization of LfhA by cellular fractionation with Triton X-114. Fractions of the detergent phase (outer membrane fraction), aqueous phase (periplasmic fraction), and protoplasmic cylinder (inner membrane plus cytoplasm fractions) were separated by SDS-PAGE and analyzed by immunoblotting using affinity-purified rabbit antiserum directed against LfhA (top panel). As a control for fractionation purity, fractions were also analyzed using rabbit antiserum to Treponema pallidum FlaB, which also recognizes the L. interrogans endoflagellum (42) (bottom panel). Spirochete flagella are anchored to the inner membrane only and thus purify with the protoplasmic cylinder. 
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LEPTOSPIRA INTERROGANS FACTOR H-BINDING PROTEIN 2663 the survival of pathogenic but not nonpathogenic Leptospira strains led to the conclusion that survival was determined by susceptibility to the alternative complement pathway cascade (3, 5, 10, (24) (25) (26) . In the present study, selective binding of factor H to pathogenic leptospires was demonstrable by visual observation using indirect immunofluorescence analysis. Supporting our conclusions, similar results were reported recently by a second research group, who demonstrated that factor H bound to infectious leptospires provided cofactor activity for degradation of C3b (40) . Our ligand affinity blot analyses of L. interrogans sonicates identified two protein bands that bound factor H, having approximate molecular masses of 30 and 50 kDa. We then isolated and characterized the novel, 26-kDa membrane protein LfhA. The identity of the larger protein is as yet unknown. LfhA bound both factor H and FHR-1 but not FHL-1, suggesting that LfhA specifically interacts with a site(s) within the carboxy-terminal SCRs 18 to 20 of factor H. The binding properties we defined for LfhA are consistent with the recent publication by Meri et al. (40) , who observed that infectious leptospires bound factor H and FHR-1 but not FHL-1. Homologs of lfhA were found in each of the L. interrogans strains we examined but were absent from other leptospires. L. weilii is associated with human leptospirosis in parts of the world but is genetically very distinct from L. interrogans (19, 60) . L. inadai possesses many features in common with saprophytic members of the genus and has been described as largely nonpathogenic, although it is occasionally isolated from humans and other animals (16, 52, 59) . Some isolates of L. inadai from India have proven to be resistant to serum (16) . Future studies on pathogenicity and serum resistance among leptospires will determine whether those species contain lfhA-like genes that are undetectable by Southern blot analysis, whether some strains possess genes similar to lfhA while other members of the same species lack such genes, or whether they utilize alternative mechanisms of resistance to complement. In support of the last hypothesis, the L. interrogans strains examined in the present studies encode at least one additional factor H-binding protein. Studies to identify and characterize that protein(s) are ongoing.
Leptospiral outer membrane proteins are potential targets for inducing protective immune responses in the host, and those that are also well conserved among pathogenic serovars make attractive vaccine candidates (11, 12, 17, 18) . Southern blot and preliminary sequence analyses suggest that LfhA may fit those criteria. We are presently assessing the potential use of LfhA in a vaccine for prevention of leptospirosis in humans and domestic animals. The usefulness of LfhA as a vaccinogen is strengthened by the possibility that antibodies which bind LfhA may also physically prevent factor H binding, thereby increasing the susceptibility of the bacterium to complementmediated killing.
In conclusion, we characterized a mechanism involved in the serum resistance of pathogenic leptospires. Pathogenic leptospires bind factor H by means of LfhA, a membrane protein which is expressed during normal mammalian infection. An lfhA gene was detected only in pathogenic strains. These findings may be helpful in the development of advanced therapeutic and/or preventive strategies to interfere with immune evasion by pathogenic Leptospira. FIG. 6 . Immunoblot analyses of LfhA with serum samples from humans and horses naturally infected with L. interrogans. Strip blots containing recombinant LfhA were probed with sera from clinically confirmed cases of human and equine leptospirosis. Normal human and equine sera and rabbit polyclonal antiserum specific for LfhA were included as controls.
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